Back to previous section

Pfizer pares back Haleon stake in £2.5bn sale

Pfizer has further reduced its holding in Haleon, it was confirmed on Wednesday, after the drugs giant offloaded 700m shares in a £2.5bn sale.

  • Haleon
  • 15 January 2025 08:49:11
Haleon

Source: Sharecast

The Wall Street firm sold the stock at 357p per ordinary share, raising around £2.5bn and reducing its 15% stake to 7.3%.

The British consumer healthcare firm - which owns Sensodyne toothpaste, Centrum vitamins and Tums, among others - was originally part of pharmaceuticals firm GSK.

It was formed through the integration of Novartis’ consumer healthcare portfolio in 2015 and Pfizer’s in 2019.

It was spun out of GSK, then called GlaxoSmithKline, in a blockbuster 2022 listing. GSK took a 13.5% stake in the blue chip, while Pfizer retained its 32% holding in the business.

However, the firm behind the Comirnaty Covid-19 vaccine has since started reducing its position, including a £2.4bn sale last autumn.

GSK has also been selling down its holding, and offloaded its remaining 4.2% stake in May last year

Shares in Haleon ticked up 1% as trading got underway on Wednesday, to 370.2p.

GSK ( GSK )

Isin: GB00BN7SWP63
Exchange: London Stock Exchange
Sell:
1,441.50 p
Buy:
1,447.50 p
Change: -36.50 ( -2.47 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

Bank of Scotland is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.

Important legal information

Bank of Scotland Share Dealing Service is operated by Halifax Share Dealing Limited. Halifax Share Dealing Limited. Registered in England and Wales No. 3195646. Registered Office: Trinity Road, Halifax, West Yorkshire HX1 2RG. Authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

Logo Allfunds

The information contained within this website is provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd unless otherwise stated. The information is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. This is a solution powered by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd incorporating their prices, data news, charts, fundamentals and investor tools on this site. Terms and conditions apply. Prices and trades are provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd and are delayed by at least 15 minutes.

FE fundinfo Logo

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

Refinitiv Logo

© 2025 Refinitiv, an LSEG business. All rights reserved.